StudyFinder

A Prospective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II Heart Failure Patients (PROACTIVE- HF-2 Trial)

Status: Recruiting

The Cordella™ Pulmonary Artery Sensor System is a possible treatment for New York Heart Association (NYHA) Class II and III heart failure. The main purpose of this study is to investigate the safety and effectiveness of the study device in helping to reduce Heart Failure hospitalizations.

I'm interested

Sex: Male or Female
Age Group: 18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• Heart Failure NYHA Class II or Class III
Exclusion Criteria:

• ACC/AHA Stage D refractory Heart Failure (HF)
• history of multiple pulmonary embolism (PE)
• resting systolic blood pressure less than 90 mmHg
Conditions:

Heart & Vascular

Keywords:

Cardiovascular, Clinics and Surgery Center (CSC), Heart Failure, HF

Study Contact: Michelle Pitt - henni032@umn.edu
Principal Investigator: Tamas Alexy
Phase: NA
IRB Number: STUDY00021914
See this study on ClinicalTrials.gov

Back